Mary Hanley, DO
Undersea and Hyperbaric Medicine · Charleston, SCNPI 1285678433
Payments from drug & device makers
Across 160 payments — averaging $414.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$63K
- KCI USA, Inc.$1K
- Smith+Nephew$714
- Reapplix Inc.$314
- Organogenesis Inc.$190
- Urgo Medical North America, LLC$171
- plus $754 from 15 others
What the payments were for
- Consulting fees$1,2002%
- Speaking & faculty fees$43,94866%
- Travel & lodging$8,63313%
- Food & beverage$5,0068%
- Education$7,60011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 59 | $63,155 |
| KCI USA, Inc. | 13 | $1,090 |
| Smith+Nephew | 32 | $714 |
| Reapplix Inc. | 10 | $314 |
| Organogenesis Inc. | 7 | $190 |
| Urgo Medical North America, LLC | 7 | $171 |
| Hydrofera LLC | 6 | $148 |
| Bioventus LLC | 2 | $116 |
| Integra Lifesciences Corporation | 4 | $79 |
| Misonix Inc | 3 | $65 |
| Solventum Corporation | 2 | $60 |
| OVIK Health, LLC | 2 | $51 |
| AbbVie | 2 | $49 |
| Cashflow Solutions, LLC | 2 | $34 |
| Johnson & Johnson | 2 | $29 |
| Paratek Pharmaceuticals, Inc. | 2 | $28 |
| Scpharmaceuticals Inc. | 1 | $22 |
| Molnlycke Health Care US, LLC | 1 | $20 |
| Convatec Inc. | 1 | $20 |
| Reddress USA, Inc. | 1 | $19 |
| Next Science LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$131,107
- Kerecis Omega3 Marigen$113,045
- Kerecis Omega3 SurgiClose$33,266
- Kerecis GraftGuide$32,777
- Kerecis Omega3 GraftGuide$2,018
- SNAP$782
- 3C Patch Kit - Box$194
- Santyl$121
- REGRANEX$121
- Oasis$121
How this compares
Too few undersea and hyperbaric medicine providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 42 | $540 |
| Cephalexin | 14 | $120 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 16 | $45 |
Paid to pharmacies, not to this prescriber.
Other undersea and hyperbaric medicine in Charleston
- Ann PassiniCharleston$137
- Robert BartlettLexington$21K
- Jerod LunsfordColumbia$2K
- Michael WhiteNewberry$1K
- David ConeColumbia$37
- Calvin TranGoose Creek$37
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.